Biotech

All Articles

Metsera teams up with Amneal to lock down GLP-1 source

.Along with early period 1 data now out in the wild, metabolic condition attire Metsera is actually ...

Rivus articles data to support muscle-sparing excessive weight drug insurance claims

.Rivus Pharmaceuticals has unveiled the data responsible for its phase 2 being overweight gain in ca...

BMS pays $110M to form T-cell therapy contract, aiding Top buy time to advance prioritized pipeline

.Bristol Myers Squibb is paying out Excellent Medication $110 million beforehand to cultivate reagen...

Generate increases another $1B-plus Huge Pharma partnership

.Novartis has printer inked a bargain potentially worth more than $1 billion along with Flagship-fou...

Metsera GLP-1 information cut uncovers 7.5% weight reduction at 36 times

.Just recently debuted Metsera is unfolding some stage 1 data for its GLP-1 receptor agonist, showin...

Flagship wishes biotechs flock to Mirai to improve hereditary medications

.Among the genetic medicines branches ethnicity, Main Pioneering is actually revealing a new company...

BioAge eyes $180M coming from IPO, private placement for excessive weight tests

.BioAge Labs is checking out around $180 million in initial earnings from an IPO as well as a person...

Merck's LAG-3 combo stops working colorectal cancer phase 3 research

.A try through Merck &amp Co. to open the microsatellite steady (MSS) metastatic colon cancer market...

Spanish VC shuts $200M life sciences fund

.Spain-based Asabys Partners has actually finalized a fund of 180 million europeans ($ 200 million),...

BioAge introduces $198M from IPO as excessive weight biotech participates in Nasdaq

.BioAge Labs is generating nearly $200 thousand using its own Nasdaq IPO today, along with the profi...